Well-differentiated fetal adenocarcinoma of the lung

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

1 event
Apr 2011

Fusilev: FDA approved

For use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

1

Copay cards

Copay Assistance1

Fusilev

Acrotech Biopharma LLC

OpenContact for detailsApply ↗

View all support programs on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Well-differentiated fetal adenocarcinoma of the lung.
Search all trials →
Search clinical trials for Well-differentiated fetal adenocarcinoma of the lung

Recent News & Research

No recent news articles indexed yet for Well-differentiated fetal adenocarcinoma of the lung.
Search PubMed for Well-differentiated fetal adenocarcinoma of the lung

Browse all Well-differentiated fetal adenocarcinoma of the lung news →

Specialist Network

No specialists currently listed for Well-differentiated fetal adenocarcinoma of the lung.

View all Well-differentiated fetal adenocarcinoma of the lung specialists →

Quick Actions